Trials / Completed
CompletedNCT06098963
Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- Cigli Regional Training Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
to report our patients' outcomes of SNM in tertiary health centres in Turkey
Detailed description
We retrospectively analyzed 18 patients who underwent SNM for urinary or bowel dysfunction between 2017 and 2022 in our clinic. We excluded 2 patients due to non-effective responses after the test period. After local ethics committee approval was obtained from our institute (Number and date: 21-12.1T/14). Patient characteristics and demographic data including age, gender, indications to the SNM, age at diagnosis, and comorbidities were collected from our Hospital patients' record system. Urinary functions were evaluated by the ICIQ-SF questionnaire form. Patients' diagnosis, implantation duration, complications, and improvement of symptoms were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | sacral neuromodulation | sacra neuromodulator implantation outcomes |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2022-01-01
- Completion
- 2023-01-01
- First posted
- 2023-10-25
- Last updated
- 2023-10-25
Source: ClinicalTrials.gov record NCT06098963. Inclusion in this directory is not an endorsement.